wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38601065-6CF71C7D-3A21-4E85-8890-D169389E6E80
Q38601065-6CF71C7D-3A21-4E85-8890-D169389E6E80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38601065-6CF71C7D-3A21-4E85-8890-D169389E6E80
TMA secondary to SLE: rituximab improves overall but not renal survival.
P2860
Q38601065-6CF71C7D-3A21-4E85-8890-D169389E6E80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38601065-6CF71C7D-3A21-4E85-8890-D169389E6E80
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f85802297ae20393b5558ca85e496754eafd5a0
P2860
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.